Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blood cancer journal

Showing results (1-10 of 1,172) with videos related to

Pageof 118
Sort By:
Blood Cancer Journal|April 18, 2015
The cellular immune system in myelomagenesis: NK cells and T cells in the development of myeloma [corrected] and their uses in immunotherapiesT Dosani, M Carlsten, I Maric, et al.
Blood Cancer Journal|May 8, 2023
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 studyThomas Martin, Meletios-Athanasios Dimopoulos, Joseph Mikhael, et al.
Blood Cancer Journal|May 19, 2023
Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapiesJean El-Cheikh, Nour Moukalled, Florent Malard, et al.
Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.
Blood Cancer Journal|July 30, 2016
New investigational drugs with single-agent activity in multiple myelomaA M Rajan, S Kumar
Blood Cancer Journal|July 30, 2016
Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myelomaP Ravi, S Kumar, J T Larsen, et al.
Blood Cancer Journal|July 18, 2015
Targeting the Pim kinases in multiple myelomaN A Keane, M Reidy, A Natoni, et al.
Blood Cancer Journal|January 20, 2018
Current applications of multiparameter flow cytometry in plasma cell disordersT Jelinek, R Bezdekova, M Zatopkova, et al.
Blood Cancer Journal|January 21, 2018
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemiaPatricia Johansson, Ludger Klein-Hitpass, Axel Choidas, et al.
Blood Cancer Journal|March 14, 2018
Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine eraRebecca L King, Grzegorz S Nowakowski, Thomas E Witzig, et al.
Pageof 118

Showing results (1-10 of 1,172) with videos related to

Sort By:
Pageof 118
Blood Cancer Journal|April 18, 2015
The cellular immune system in myelomagenesis: NK cells and T cells in the development of myeloma [corrected] and their uses in immunotherapiesT Dosani, M Carlsten, I Maric, et al.
Blood Cancer Journal|May 8, 2023
Isatuximab, carfilzomib, and dexamethasone in patients with relapsed multiple myeloma: updated results from IKEMA, a randomized Phase 3 studyThomas Martin, Meletios-Athanasios Dimopoulos, Joseph Mikhael, et al.
Blood Cancer Journal|May 19, 2023
Cardiac toxicities in multiple myeloma: an updated and a deeper look into the effect of different medications and novel therapiesJean El-Cheikh, Nour Moukalled, Florent Malard, et al.
Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.
Blood Cancer Journal|July 30, 2016
New investigational drugs with single-agent activity in multiple myelomaA M Rajan, S Kumar
Blood Cancer Journal|July 30, 2016
Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myelomaP Ravi, S Kumar, J T Larsen, et al.
Blood Cancer Journal|July 18, 2015
Targeting the Pim kinases in multiple myelomaN A Keane, M Reidy, A Natoni, et al.
Blood Cancer Journal|January 20, 2018
Current applications of multiparameter flow cytometry in plasma cell disordersT Jelinek, R Bezdekova, M Zatopkova, et al.
Blood Cancer Journal|January 21, 2018
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemiaPatricia Johansson, Ludger Klein-Hitpass, Axel Choidas, et al.
Blood Cancer Journal|March 14, 2018
Rapid, real time pathology review for ECOG/ACRIN 1412: a novel and successful paradigm for future lymphoma clinical trials in the precision medicine eraRebecca L King, Grzegorz S Nowakowski, Thomas E Witzig, et al.
Pageof 118